The FDA today approved a drug from Belgium's UCB as an add-on therapy to treat partial seizures caused by epilepsy. The drug, branded Briviact, has also been recommended for approval in Europe. The FDA pointed out that people with epilepsy can have different responses to available treatments so it is important to have more options. Release | More